×
About 270 results

ALLMedicine™ Hypertensive Encephalopathy Center

Research & Reviews  91 results

Managing severe hypertension in children.
https://doi.org/10.1007/s00467-023-05896-z
Pediatric Nephrology (Berlin, Germany); Coulthard MG

Mar 3rd, 2023 - Severe childhood hypertension is uncommon and frequently not recognised and is best defined as a systolic blood pressure (SBP) above the stage 2 threshold of the 95th centile + 12 mmHg. If no signs of end-organ damage are present, this is urgent h...

Beneficial effects of the phytoestrogen genistein on hippocampal impairments of spontan...
https://doi.org/10.1111/jne.13228
Journal of Neuroendocrinology; Ronchetti S, Labombarda F et. al.

Jan 24th, 2023 - Hippocampal neuropathology is a recognized feature of the spontaneously hypertensive rat (SHR). The hippocampal alterations associate with cognitive impairment. We have shown that hippocampal abnormalities are reversed by 17β-estradiol, a steroid ...

Hyperaldosteronism
https://emedicine.medscape.com/article/920713-print

Jan 9th, 2023 - Practice Essentials Hyperaldosteronism is characterized by excessive secretion of aldosterone, which causes increases in sodium reabsorption and loss of potassium and hydrogen ions. It may be either primary (autonomous) or secondary.[1, 2] Hyperal...

Hyperaldosteronism
https://emedicine.medscape.com/article/920713-overview

Jan 9th, 2023 - Practice Essentials Hyperaldosteronism is characterized by excessive secretion of aldosterone, which causes increases in sodium reabsorption and loss of potassium and hydrogen ions. It may be either primary (autonomous) or secondary. [1, 2] Hypera...

Hyperaldosteronism
http://emedicine.medscape.com/article/920713-overview

Jan 9th, 2023 - Practice Essentials Hyperaldosteronism is characterized by excessive secretion of aldosterone, which causes increases in sodium reabsorption and loss of potassium and hydrogen ions. It may be either primary (autonomous) or secondary. [1, 2] Hypera...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  4 results

Furosemide vs. Placebo for Severe Antepartum Hypertension
https://clinicaltrials.gov/ct2/show/NCT04615624

May 3rd, 2022 - Blood pressure is a measure of blood flow and resistance in blood vessels. In normal pregnancy, total blood volume increases while systemic vascular resistance decreases, thereby leading to an overall reduction in blood pressure with return to bas...

Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
https://clinicaltrials.gov/ct2/show/NCT00879359

Apr 26th, 2017 - Exclusion Criteria Disease-Specific Exclusions Patients with a concomitant malignancy other than non-melanoma skin cancer. Patients with a prior malignancy who have been disease-free for greater than 5 years or who received prior chemotherapy for ...

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT00537173

Jan 25th, 2017 - OUTLINE: This is a multi-center study. Sample Collection: Core biopsy Blood sample 28-day Cycle Treatment Regimen: Paclitaxel 90 mg/m2 IV D1, 8, and 15 Avastin 10 mg/kg IV D1 and 15 ECOG Performance Status of 0 or 1 Life Expectancy: Not specified ...

Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
https://clinicaltrials.gov/ct2/show/NCT01575652

Apr 11th, 2012 - This prospective cohort study was conducted at the Unit of Nephrology of Sisli Etfal Education and Research Hospital, Istanbul, Turkey. Prior to subject recruitment, the study protocol was reviewed and approved by the local ethics committee, in ac...

see more →

News  11 results

FDA Approves Third Bevacizumab Biosimilar
https://www.onclive.com/view/fda-approves-third-bevacizumab-biosimilar

Apr 25th, 2022 - The FDA has approved bevacizumab-maly (Almysys), a biosimilar of bevacizumab (Avastin). This regulatory decision represents the third bevacizumab biosimilar to receive the green light in the United States.1,2 The biosimilar was developed by the g...

Encephalopathy Common, Often Lethal in Hospitalized COVID-19 Patients
https://www.medscape.com/viewarticle/948113

Mar 25th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Toxic metabolic encephalopathy (TME) is common and often lethal in hospitalized patients with COVID-19, new research shows. "A lot of the delirium...

Recognition, evaluation, and management of postpartum hypertension
https://www.mdedge.com/obgyn/article/197631/obstetrics/recognition-evaluation-and-management-postpartum-hypertension
Baha M. Sibai, MD

Mar 27th, 2019 - Postpartum hypertension has a host of potential causes, some of which may be benign (such as the persistence of mild gestational hypertension or mild chronic hypertension) whereas others (such as severe de novo preeclampsia-eclampsia and HELLP syn.

Subunit Vaccine Against TB Shows Promising Results in Phase IIb Trial
https://www.medpagetoday.com/infectiousdisease/tuberculosis/75306

Sep 25th, 2018 - The incidence of primary tuberculosis was significantly lower following administration of the subunit M72/AS01E vaccine compared with placebo, a phase IIb trial found. In a randomized trial, vaccine efficacy for the M72/AS01E tuberculosis vaccine ...

A Review of Neurologic Complications of Biologic Therapy in Plaque Psoriasis
https://www.mdedge.com/dermatology/article/155649/psoriasis/review-neurologic-complications-biologic-therapy-plaque
Elaine J. Lin, MD, Shivani Reddy, MD et. al.

Jan 8th, 2018 - Biologic agents have provided patients with moderate to severe psoriasis with treatment alternatives that have improved systemic safety profiles and disease control1; however, case reports of associated neurologic complications have been emerging.

see more →